Back to News
Market Impact: 0.35

Pagaya (PGY) CFO Perros sells $92k in shares

PGYCF.TOCIA
FintechInsider TransactionsCorporate EarningsCorporate Guidance & OutlookAnalyst EstimatesCompany FundamentalsCredit & Bond Markets
Pagaya (PGY) CFO Perros sells $92k in shares

CFO Evangelos Perros sold 8,425 shares on Mar 12, 2026 at $10.99 for $92,590 to cover tax withholding, exercised 20,625 RSU-derived options, and now directly owns 112,412 shares. Pagaya shares trade at $10.99, down 73.8% over six months. The company closed a $400M auto ABS (RPM 2026-1) with participation from 20+ investors (62% YoY increase in investor involvement). Multiple brokers lowered price targets after Q4 2025 results—Benchmark $33, Canaccord $32, Stephens $25, Citizens $22—following a modest revenue miss and softer Q1 2026 guidance despite Net Income and EPS beating expectations.

Analysis

Pagaya sits at the intersection of fintech credit origination and capital markets distribution; its auto-ABS competency is a double-edged sword that converts loan-flow into fee and financing income but is highly sensitive to investor appetite and spread compression. As securitization windows open, revenue can scale quickly without proportional incremental fixed costs, creating high operating leverage — however, that same leverage accelerates downside when delinquencies or funding costs move against the stack. Near-term inflection points are dominated by funding and sentiment: ABS placement cadence, warehouse financing renewals, and quarterly guidance will move the stock in days-to-weeks, while macro credit cycles and delinquencies govern the 6–18 month fundamental outcome. Tail risks include a sudden pullback in ABS demand or a regulatory change restricting automated underwriting—events that can tighten spreads and force valuation resets; the primary reversals are improving ABS take-up, tighter loss curves, or visible operating leverage translating to margin expansion. For portfolio construction, this is a classic asymmetric idea where optionality from balance-sheet-lite scaling meets concentrated execution risk. If you expect investor demand for structured credit to remain constructive, the path to a >2x equity re-rating is clear once a few consecutive issuance cycles show lower yields and stable loss rates; conversely, a funding shock could produce 30–50% downside quickly, so size and convexity must be managed. Consensus is focused on headline volatility and near-term guidance misses but underweights the recurring nature of placement fees and the potential step-change in funding cost if investor breadth continues to diversify. That makes the move plausibly overdone for patient, event-driven capitalists who can stomach 6–12 month execution risk and actively monitor ABS supply/demand metrics.